Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis

Nadege Nziza^#¹, Deniz Cizmeci^#¹, Leela Davies^{1

2}, Edward B Irvine^{1

3}, Wonyeong Jung¹, Brooke A Fenderson¹, Marwou de Kock⁴, Willem A Hanekom^{5

6}, Kees L M C Franken⁷, Cheryl L Day⁸, Tom H M Ottenhoff⁷, Galit Alter¹

Affiliations

¹ Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
² Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, United States.
³ Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
⁴ South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
⁵ Africa Health Research Institute, Durban, South Africa.
⁶ Division of Infection and Immunity, University College London, London, United Kingdom.
⁷ Department of Infectious Disease, Leiden University, Leiden, Netherlands.
⁸ Department of Microbiology and Immunology, Emory University School of Medicine, Emory University, Atlanta, GA, United States.

^# Contributed equally.

Published Erratum

Nadege Nziza et al. Front Immunol. 2023.

. 2023 Nov 21:14:1329784.

doi: 10.3389/fimmu.2023.1329784. eCollection 2023.

¹ Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
² Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, United States.
³ Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
⁴ South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
⁵ Africa Health Research Institute, Durban, South Africa.
⁶ Division of Infection and Immunity, University College London, London, United Kingdom.
⁷ Department of Infectious Disease, Leiden University, Leiden, Netherlands.
⁸ Department of Microbiology and Immunology, Emory University School of Medicine, Emory University, Atlanta, GA, United States.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.856906.].

Keywords: HIV; active and latent tuberculosis; antibodies; biomarkers; diagnostics.

Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis.
Nziza N, Cizmeci D, Davies L, Irvine EB, Jung W, Fenderson BA, de Kock M, Hanekom WA, Franken KLMC, Day CL, Ottenhoff THM, Alter G. Nziza N, et al. Front Immunol. 2022 Apr 20;13:856906. doi: 10.3389/fimmu.2022.856906. eCollection 2022. Front Immunol. 2022. PMID: 35514994 Free PMC article.